Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion

Neuroscience

Volumn 202, Issue , 2012, Pages 158-168

  Csati, A ^a,b   Tajti, J ^a,b   Kuris, A ^a,b   Tuka, B ^a   Edvinsson, L ^b,c   Warfvinge, K ^b,c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Neuron; Nitric oxide synthase; Pituitary adenylate cyclase activating peptide; Receptors; Sphenopalatine ganglion; Vasoactive intestinal peptide

Indexed keywords

DUAL SPECIFICITY PHOSPHATASE 2; EOSIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; HEMATOXYLIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NITRIC OXIDE SYNTHASE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ADRENERGIC TRANSMISSION; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CONTROLLED STUDY; ENZYME LOCALIZATION; GANGLION; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; MALE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PTERYGOPALATINE GANGLION; RAT; SATELLITE CELL; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANIMALS; BLOTTING, WESTERN; CADAVER; COLORING AGENTS; FEMALE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GANGLIA, PARASYMPATHETIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NITRIC OXIDE SYNTHASE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; RHODAMINES; SPECIES SPECIFICITY; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84856226951     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.10.055     Document Type: Article

References (54)

1. Barbanti P., Fabbrini G., Pesare M., Vanacore N., Cerbo R. Unilateral cranial autonomic symptoms in migraine. Cephalalgia 2002, 22:256-259.
2. Baun M., Hay-Schmidt A., Edvinsson L., Olesen J., Jansen-Olesen I. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat (in press). Eur J Pharmacol 2011, 16:186-194.
3. Birk S., Kruuse C., Petersen K.A., Jonassen O., Tfelt-Hansen P., Olesen J. The phosphodiesterase 3 inhibitor cilostazol dilates large cerebral arteries in humans without affecting regional cerebral blood flow. J Cereb Blood Flow Metab 2004, 24:1352-1358.
4. Birk S., Kruuse C., Petersen K.A., Tfelt-Hansen P., Olesen J. The headache-inducing effect of cilostazol in human volunteers. Cephalalgia 2006, 26:1304-1309.
5. Birk S., Sitarz J.T., Petersen K.A., Oturai P.S., Kruuse C., Fahrenkrug J., Olesen J. The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers. Regul Pept 2007, 140:185-191.
6. Bolay H., Reuter U., Dunn A.K., Huang Z., Boas D.A., Moskowitz M.A. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002, 8:136-142.
7. Boni L.J., Ploug K.B., Olesen J., Jansen-Olesen I., Gupta S. The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery. Cephalalgia 2009, 29:837-847.
8. Burstein R., Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 2005, 493:9-14.
9. Chan K.Y., Baun M., de Vries R., van den Bogaerdt A.J., Dirven C.M., Danser A.H., Jansen-Olesen I., Olesen J., Villalón C.M., MaassenVanDenBrink A., Gupta S. Pharmacological characterization of VIP and PACAP receptors in the human meningeal and coronary artery. Cephalalgia 2011, 31:181-189.
10. Delépine L., Aubineau P. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion. Exp Neurol 1997, 147:389-400.
11. Dickson L., Aramori I., McCulloch J., Sharkey J., Finlayson K. A systematic comparison of intracellular cyclic AMP and calcium signaling highlights complexities in human VPAC/PAC receptor pharmacology. Neuropharmacology 2006, 51:1086-1098.
12. Dickson L., Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol Ther 2009, 121:294-316.
13. Edvinsson L., Elsås T., Suzuki N., Shimizu T., Lee T.J. Origin and co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc Res Tech 2001, 53:221-228.
14. Edvinsson L., Hara H., Uddman R. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides. J Cereb Blood Flow Metab 1989, 9:212-218.
15. Edvinsson L., Uddman R. Adrenergic, cholinergic and peptidergic nerve fibres in dura mater-involvement in headache?. Cephalalgia 1981, 1:175-179.
16. Edvinsson L., Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev 2005, 48:438-456.
17. Goadsby P.J., Charbit A.R., Andreou A.P., Akerman S., Holland P.R. Neurobiology of migraine. Neuroscience 2009, 161:327-341.
18. Goadsby P.J., Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994, 117(Pt 3):427-434.
19. Goadsby P.J., Edvinsson L., Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28:183-187.
20. Hanani M. Satellite glial cells in sympathetic and parasympathetic ganglia: in search of function. Brain Res Rev 2010, 64:304-327.
21. Hansen J.M., Sitarz J., Birk S., Rahmann A.M., Oturai P.S., Fahrenkrug J., Olesen J., Ashina M. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia 2006, 26:992-1003.
22. Hara H., Weir B. Pathway of nerves with vasoactive intestinal polypeptide-like immunoreactivity to the major cerebral arteries of the rat. Cell Tissue Res 1988, 251:275-280.
23. Hara H., Zhang Q.J., Kuroyanagi T., Kobayashi S. Parasympathetic cerebrovascular innervation: an anterograde tracing from the sphenopalatine ganglion in the rat. Neurosurgery 1993, 32:822-827. discussion 827.
24. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschek J.A. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 1998, 50:265-270. International Union of Pharmacology. XVIII.
25. Ho T.W., Edvinsson L., Goadsby P.J. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 2010, 6:573-582.
26. Hua X.Y., Back S.M., Yaksh T.L. Characterization of muscarinic receptors involved in tracheal CGRP release. Neuroreport 1994, 5:2133-2136.
27. Ingram S.L., Williams J.T. Modulation of the hyperpolarization-activated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons. J Physiol 1996, 492(Pt 1):97-106.
28. Jansen-Olesen I., Gulbenkian S., Engel U., Cunha e Sá M., Edvinsson L. Peptidergic and non-peptidergic innervation and vasomotor responses of human lenticulostriate and posterior cerebral arteries. Peptides 2004, 25:2105-2114.
29. Knutsson M., Edvinsson L. Distribution of mRNA for VIP and PACAP receptors in human cerebral arteries and cranial ganglia. Neuroreport 2002, 13:507-509.
30. Lassen L.H., Haderslev P.A., Jacobsen V.B., Iversen H.K., Sperling B., Olesen J. CGRP may play a causative role in migraine. Cephalalgia 2002, 22:54-61.
31. Lee T.J., Saito A., Berezin I. Vasoactive intestinal polypeptide-like substance: the potential transmitter for cerebral vasodilation. Science 1984, 224:898-901.
32. Lorén I., Emson P.C., Fahrenkrug J., Björklund A., Alumets J., Håkanson R., Sundler F. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience 1979, 4:1953-1976.
33. Minami Y., Kimura H., Aimi Y., Vincent S.R. Projections of nitric oxide synthase-containing fibers from the sphenopalatine ganglion to cerebral arteries in the rat. Neuroscience 1994, 60:745-759.
34. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., Culler M.D., Coy D.H. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989, 164:567-574.
35. Nozaki K., Moskowitz M.A., Maynard K.I., Koketsu N., Dawson T.M., Bredt D.S., Snyder S.H. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J Cereb Blood Flow Metab 1993, 13:70-79.
36. Rahmann A., Wienecke T., Hansen J.M., Fahrenkrug J., Olesen J., Ashina M. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 2008, 28:226-236.
37. Said S.I. Vasoactive intestinal polypeptide (VIP): current status. Peptides 1984, 5:143-150.
38. Said S.I., Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature 1970, 225:863-864.
39. Schytz H.W., Birk S., Wienecke T., Kruuse C., Olesen J., Ashina M. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 2009, 132:16-25.
40. Schytz H.W., Olesen J., Ashina M. The PACAP receptor: a novel target for migraine treatment. Neurotherapeutics 2010, 7:191-196.
41. Steen K.H., Reeh P.W. Actions of cholinergic agonists and antagonists on sensory nerve endings in rat skin, in vitro. J Neurophysiol 1993, 70:397-405.
42. Sundler F., Ekblad E., Hannibal J., Moller K., Zhang Y.Z., Mulder H., Elsas T., Grunditz T., Danielsen N., Fahrenkrug J., Uddman R. Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation. Ann N Y Acad Sci 1996, 805:410-426. discussion 427-428.
43. Suzuki N., Hardebo J.E., Owman C. Origins and pathways of cerebrovascular vasoactive intestinal polypeptide-positive nerves in rat. J Cereb Blood Flow Metab 1988, 8:697-712.
44. Tajti J., Uddman R., Möller S., Sundler F., Edvinsson L. Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 1999, 76:176-183.
45. Tanelian D.L. Cholinergic activation of a population of corneal afferent nerves. Exp Brain Res 1991, 86:414-420.
46. Tepper S.J., Rezai A., Narouze S., Steiner C., Mohajer P., Ansarinia M. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache 2009, 49:983-989.
47. Uddman R., Goadsby P.J., Jansen I., Edvinsson L. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J Cereb Blood Flow Metab 1993, 13:291-297.
48. Uddman R., Tajti J., Hou M., Sundler F., Edvinsson L. Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2. Cephalalgia 2002, 22:112-116.
49. Uddman R., Tajti J., Möller S., Sundler F., Edvinsson L. Neuronal messengers and peptide receptors in the human sphenopalatine and otic ganglia. Brain Res 1999, 826:193-199.
50. Vaudry H., Laburthe M. VIP, PACAP, and related peptides-from gene to therapy 2006, Blackwell Publishing.
51. Walker C.S., Conner A.C., Poyner D.R., Hay D.L. Regulation of signal transduction by calcitonin gene-related peptide receptors. Trends Pharmacol Sci 2010, 31:476-483.
52. Yarnitsky D., Goor-Aryeh I., Bajwa Z.H., Ransil B.I., Cutrer F.M., Sottile A., Burstein R. 2003 Wolff Award: possible parasympathetic contributions to peripheral and central sensitization during migraine. Headache 2003, 43:704-714.
53. Zagami A.S., Edvinsson L., Goadsby P.J. Stimulation of the superior sagittal sinus causes extracranial release of PACAP. Cephalalgia 1995, 15(suppl 14):109.
54. Zagami A.S., Goadsby P.J., Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990, 16:69-75.